Condition
Dermatillomania
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
3 of 3 completed with results
Key Signals
3 with results100% success
Data Visualizations
Phase Distribution
4Total
P 2 (4)
Trial Status
Completed3
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05545891Phase 2Not Yet Recruiting
Aripiprazole in Body Focused Repetitive Behaviors
NCT04792645Phase 2Completed
Memantine in Body Focused Repetitive Behaviors
NCT01063348Phase 2Completed
N-Acetyl Cysteine in Pathologic Skin Picking
NCT00513019Phase 2Completed
Double-Blind Lamictal (Lamotrigine) in Neurotic Excoriation
Showing all 4 trials